Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB1 | P15086 | 1/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.36 |
| ▸ | NCF1 | P14598 | 1/20 | 0.35 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.33 |
| ▸ | TPH1 | P17752 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.30 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16793052 | 0.77 | TPH1 (0.42) | CPB1CPB2NCF1TPH1 | |
| SCHEMBL30607719 | 0.77 | NCF1 (0.36) | NCF1 | |
| SCHEMBL30332311 | 0.74 | CYP1A2 (0.46) | NCF1 | |
| SCHEMBL30332384 | 0.72 | HCRTR1 (0.35) | NCF1TPH1F2F10HCRTR1 | |
| SCHEMBL21486445 | 0.72 | HCRTR1 (0.35) | NCF1TPH1F2F10HCRTR1 | |
| SCHEMBL30607575 | 0.71 | KMT2A (0.37) | NCF1HCAR1ALDH1A1LMNAHPGD | |
| SCHEMBL30332432 | 0.71 | HCRTR1 (0.39) | NCF1F2F10HCRTR1HCRTR2 | |
| SCHEMBL30607571 | 0.70 | F10 (0.40) | NCF1F2F10ALDH1A1HPGD | |
| SCHEMBL5855702 | 0.69 | NCF1 (0.41) | NCF1 | |
| SCHEMBL30332392 | 0.69 | HCRTR1 (0.38) | NCF1F2F10HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023046128-A1 | A CYCLIN-DEPENDENT KINASE INHIBITOR | Taizhou Eoc Pharma Co., Ltd. (CN) | 2023-03-30 | — | — | WO | disclosed |